Skip to content

Effect of Gojihvadi Syrup and Anu Taila Nasya in managing childhod recurrent cold

Randomised clinical trial for determination of efficacy of Gojihvadi syrup and Anu taila nasya in managing childhood allergic rhinitis

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014165
Enrollment
100
Registered
2018-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Childhood Allergic Rhinitis

Interventions

Intervention1: Gojihvadi syrup Anu taila: Gojihvadi syrup dose 7-8 years 36 ml/day TID,9-10 years 38 ml/day TID,11-12 years 40 ml/day TID,13-14 years 42 ml/day TID,15-16 years 44 ml/day TID for 6 week

Sponsors

ALL INDIA INSTITUTE OF AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Presence of Cardinal features of Pratishaya like kasa, Nasa Srava, Ghranoparodha, Gandhagyan, Galashotha, Shwaskashtata, Akshikandu, Sashabdaswaas, Shirahshoola, Jwara, Kshwathu, Swarasada. 3. Recurrence of at least one episode every month for last one year or more. 4. Patients who are willing to participate in the study and come for follow up

Exclusion criteria

Exclusion criteria: Severe and Complicated respiratory allergic disorders. 2. Other respiratory infectious conditions such as Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchieactasis, pneumonia, Pleurisy. 3. Upper Respiratory complaints such as Nasal polyposis, Nasal tumours. 4. Congenital anomalies of respiratory tract. 5. Children with chronic debilitating diseases like JDM, HIV, HBsAg, immune compromised children etc. 6. Patients who are not willing to be included in the study protocol and also who are not willing to give the consent for the study.

Design outcomes

Primary

MeasureTime frame
Reduction in severity score of Allergic rhinitis.Timepoint: Reduction in severity score of Allergic rhinitis.

Secondary

MeasureTime frame
Changes in the Quality of Life of children in both the groups according to WHO.Timepoint: at the end of the study

Countries

India

Contacts

Public ContactDr Rajagopala S

ALL INDIA INSTITUTE OF AYURVEDA

ak_ayu@yahoo.co.in8800543828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026